PeriGen CMO co-authors article on factors predictive of adverse neonatal outcomes <32 weeks

Hamlet said that “Brevity is the soul of wit,” but we say that Brevity and her cousins Clarity and Simplicity are the souls of a good medical publication. Furthermore, when that publication helps us streamline clinical practice, we have a real find.

Dr. Thomas Garite, PeriGen’s Chief Medical Officer, recently helped co-author an article appearing in the July issue of the American Journal of Obstetrics & Gynecology that provides information to help counsel pregnant women who are admitted before 32 weeks gestation.

The authors examined several clearly identifiable factors known at admission or just before delivery to determine which ones were most predictive of adverse neonatal outcome. Among the factors examined, only gestational age and suspected fetal growth restriction were significantly and independently associated with higher rates of serious neonatal morbidity.

https://www.ncbi.nlm.nih.gov/pubmed/28267444

Garite TJ, Combs CA, Maurel K, Das A, Huls K, Porreco R, Reisner D, Lu G, Bush M, Morris B, Bleich A; Obstetrix Collaborative Research Network. A multicenter prospective study of neonatal outcomes at less than 32 weeks associated with indications for maternal admission and delivery. Am J Obstet Gynecol. 2017 Jul;217(1):72.e1-72.e9

By | 2017-06-29T20:22:05+00:00 June 29th, 2017|Articles, Media Coverage, News, Research Papers, Resources, Uncategorized, Updates|Comments Off on PeriGen CMO co-authors article on factors predictive of adverse neonatal outcomes <32 weeks

About the Author: